Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: Finding the Optimal Regimen for Mycobacterium Abscessus Treatment [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial led by The University of Queensland is investigating the optimal treatment regimen for pulmonary disease caused by Mycobacteriu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Queensland | Conditions: Pulmonary Disease Due to Mycobacteria (Diagnosis) | Phase 2, Phase 3 | Status: RECRUITING